AI Science Tracker
EN

An Integrative Nomogram for Identifying Early-Stage Parkinson's Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers From Whole-Brain MRI

Zhejiang Provincial People’s Hospital; Affiliated People's Hospital of Hangzhou Medical College · 17 Dec 2020 · medicine

Discovery

An Integrative Nomogram for Identifying Early-Stage Parkinson's Disease Using Non-motor Symptoms and White Matter-Based Radiomics Biomarkers From Whole-Brain MRI

Source check: Source checked. Not independent scientific confirmation.

Finding: An ML nomogram combined white-matter MRI radiomics and nonmotor symptoms to identify early PD; it was evaluated on held-out PPMI subjects and a 58-person SWEDD verification group. This is retrospective diagnostic evidence, not a clinical-outcome claim. Methods: PPMI 336 subjects (168 PD), random training/test split, white-matter MRI radiomics plus nonmotor symptoms, ML nomogram; independent SWEDD set n=58. Results report AUC 0.937 training, 0.922 testing, 0.836 SWEDD verification.

Technology: PPMI 336 subjects (168 PD), random training/test split, white-matter MRI radiomics plus nonmotor symptoms, ML nomogram; independent SWEDD set n=58. Results report AUC 0.937 training, 0.922 testing, 0.836 SWEDD verification.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
PPMI 336 subjects (168 PD), random training/test split, white-matter MRI radiomics plus nonmotor symptoms, ML nomogram; independent SWEDD set n=58. Results report AUC 0.937 training, 0.922 testing, 0.836 SWEDD verification.
Test and result
PPMI 336 subjects (168 PD), random training/test split, white-matter MRI radiomics plus nonmotor symptoms, ML nomogram; independent SWEDD set n=58. Results report AUC 0.937 training, 0.922 testing, 0.836 SWEDD verification.
Limitation / still unknown
Methods: PPMI 336 subjects (168 PD), random training/test split, white-matter MRI radiomics plus nonmotor symptoms, ML nomogram; independent SWEDD set n=58. Results report AUC 0.937 training, 0.922 testing, 0.836 SWEDD verification. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2020.548616/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.